T: 15527131509 "product name plus anti gatifloxacin chemical name 3,4-dihydro-4-oxo-3-quinoline carboxylic acid antibiotics infective drug use specifications 25kg quality standards enterprise standard Appearance white or light yellow crystalline powder Content 99 (%) shelf life of 24 (months) CAS 180200-66-2 Product Name Product Name Gatifloxacin Gatifloxacin quality standards enterprise standard Appearance white or light yellow powder Content ≥98.5% (%) heavy metal ≤0.002 % (ppm) use for the production of fluoroquinolone drugs cas: 180200-66-2 English name: Gatifloxacin Physical Properties: This product is white or light yellow crystalline powder, soluble in water, methanol main purposes: the middle of pharmaceutical raw materials body, for the production of fluoroquinolone drugs Packing: 25 kg drum or according to customer requirements pharmacological effects of gatifloxacin 8-methoxy fluoroquinolone racemic compounds in vitro spectrum has to be anti-Gram positive and gram-negative microbial activity, its R- and S- enantiomers of the same antibacterial activity. This product antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby inhibiting bacterial DNA replication, transcription and repair process In vitro tests and clinical results show that the use of most strains of the following microorganisms has antibacterial activity: 1, Gram-positive bacteria: Staphylococcus aureus (methicillin-susceptible only to strains), Streptococcus pneumoniae (for penicillin-susceptible strains) 2, Gram-negative bacteria: E. coli, Haemophilus influenza and parainfluenza, Klebsiella pneumoniae, Moraxella catarrhalis, Neisseria disease, Proteus mirabilis 3, other microorganisms. : Chlamydia pneumoniae, Legionella pneumophila bacteria, Mycoplasma pneumoniae Indications This product is mainly used by sensitive pathogens caused by a variety of infectious diseases, including acute exacerbation of chronic bronchitis, acute sinusitis, community-acquired pneumonia. simple urinary tract infections (cystitis) and complicated urinary tract infections, acute pyelonephritis, urinary tract inflammation or male rectal gonococcal infection and female cervical gonococcal infection. "